MONMOUTH JUNCTION, N.J., & AUCKLAND, New Zealand--(BUSINESS WIRE)-- MicroDose Therapeutx, Inc. (MicroDose) and Nexus6 today announced that they have entered into a non-exclusive agreement whereby ...
MicroDose Therapeutx Announces Successful Completion of Phase 1 Pilot Study with Inhaled Atropine as Antidote to Combat Effects of Nerve Agent Poisoning MONMOUTH JUNCTION, N.J.--(BUSINESS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback